Platinum Asia Fund (Quoted Managed Hedge Fund)

PAXX

PAXX.AX was created on 2017-08-17 by Platinum. The fund's investment portfolio concentrates primarily on multi-strategy alternatives. The Fund aims to provide capital growth over the long-term by providing exposure to undervalued listed investments in the Asian region excluding Japan.

PointsBet

PBH

PointsBet Holdings Ltd. engages in the provision of racing and sports betting products and services direct to clients via its scalable cloud-based technology platform. The firm has developed a cloud-based wagering platform through which it offers its clients advanced sports and racing wagering products, and iGaming. The Company’s segments include Australian Trading, Canadian Trading, Technology, and Corporate. The Australian Trading segment provides online sports and online fixed odds racing betting services to Australian customers. The Canadian trading segment offers sports betting and iGaming services provided to Canadian customers. The Technology segment derives its internal revenue from licensing fees charged to the Australian Trading and Canadian Trading segments. The Technology segment offers external B2B services. The Company’s product includes Fixed Odds Sports, Fixed Odds Racing, PointsBetting, and iGaming.

Paradigm Biopharmaceuticals Limited.

PAR

Paradigm Biopharmaceuticals Ltd. is a biopharmaceutical company engaged in researching and developing therapeutic products for human use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-08-19. The firm is engaged in discovering, developing, and delivering pharmaceutical therapies. The company is focused on the development of injectable pentosan polysulfate sodium (iPPS/PPS) for the treatment of osteoarthritis (OA) and mucopolysaccharidosis (MPS). Pentosan polysulfate sodium is a semi-synthetic drug manufactured from the wood chips of European beech trees. Extracted glucurono-xylans are sulfated to produce a negatively charged product that mimics glycosaminoglycans (GAGs). The company develops PPS under the brand name Zilosul. PPS also inhibits the synthesis of the metalloproteinase, MMP-3 (Troeberg) involved in degrading cartilage. PPS also include treatment of joint function, mobility, and pain in patients with MPS; treating alphavirus-induced arthralgia (such as Ross River virus and Chikungunya); chronic heart failure (HF) and acute respiratory distress syndrome (ARDS).

Patriot Lithium Limited

PAT

Patriot Lithium Ltd. provides exploration services. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2022-12-09. The firm is engaged in exploring high-grade lithium projects across North America. The Company’s projects include the Gormon Project, Keystone & Tinton West Projects, Wickenburg Project, Forester Project, Birkett Project, Pak East Project, Dryden Project, Bull Project, Sydney Project, and Borland Project. The Gorman Project covers about 72 multi-cell mining claims for a total area of 320 square kilometers. The Keystone Project comprises 255 unpatented lode mining claims in four separate blocks that are 100% held by the Company. The Tinton West Project is situated in the northern Black Hills straddling the boundary between Lawrence County, South Dakota, and Crook County, Wyoming. The Forester Project covers about 36 multi-cell mining claims for a total area of 145 square kilometers. The Birkett Project comprises six mining claims for a total area of about 25 square kilometers. The Pak East Project covers eight multi-cell mining claims.